Overall survival with cisplatin–gemcitabine and bevacizumab or placebo as first-line therapy for nonsquamous non-small-cell lung cancer: results from a randomised phase III trial (AVAiL)
Titel:
Overall survival with cisplatin–gemcitabine and bevacizumab or placebo as first-line therapy for nonsquamous non-small-cell lung cancer: results from a randomised phase III trial (AVAiL)
Auteur:
Reck, M. von Pawel, J. Zatloukal, P. Ramlau, R. Gorbounova, V. Hirsh, V. Leighl, N. Mezger, J. Archer, V. Moore, N. Manegold, C.